Results from different studies suggest that GBA2 might be a modifying factor in the phenotypic expression of at least some Gaucher disease patients [25], however, we show that a defect in GBA2 is sufficient to elevate the levels of glucosylceramide to similar levels as seen in patients with Gaucher disease. Here, GBA2 is linked to Gaucher disease.